ACTR-79. ESTABLISHMENT OF CLINICAL PROTOCOL TARGETING CANCER STEM CELLS IN RECURRENT GLIOBLASTOMA USING HIGH-THROUGHPUT DRUG SCREENING

Despite aggressive multimodal oncological treatment, glioblastoma (GBM) disease progresses within 10 months. Due to the lack of treatment options for the relapsed disease, enrollment in clinical trials may be the best option. However, the fundamental preclinical studies leading to clinical investiga...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Skaga, Erlend, Kulesskiy, Evgeny, Brynjulfsen, Marit, Sandberg, Cecilie Jonsgar, Kyttälä, Aija, Langmoen, Iver Arne, Laakso, Aki, Gaál-Paavola, Emília, Perola, Markus, Wennerberg, Krister, Vik-Mo, Einar Osland
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692302/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.066
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars